COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab.
Betacoronavirus
COVID-19
Carcinoma, Renal Cell
/ complications
Coronavirus Infections
/ complications
Diagnosis, Differential
Fluorodeoxyglucose F18
Humans
Immunotherapy
/ adverse effects
Kidney Neoplasms
/ complications
Male
Middle Aged
Nivolumab
/ adverse effects
Pandemics
Pneumonia
/ diagnostic imaging
Pneumonia, Viral
/ complications
Positron Emission Tomography Computed Tomography
SARS-CoV-2
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
11
6
2020
medline:
14
7
2020
entrez:
11
6
2020
Statut:
ppublish
Résumé
Within a few months, coronavirus disease 2019 (COVID-19) has become a pandemic with more than 2 million patients infected and a high mortality rate. Early detection of COVID-19 in oncologic patients is crucial in order to rapidly apply isolation measures and avoid nosocomial spread. However, early diagnosis may be challenging, especially in cancer patients under treatment with immunotherapy as drug-induced pneumonitis can present similar clinical and radiological features. We describe the findings of a SARS-CoV-2 infection on PET/CT with F-FDG in a 51-year-old man with metastatic renal cell carcinoma under treatment with nivolumab.
Identifiants
pubmed: 32520508
doi: 10.1097/RLU.0000000000003152
pmc: PMC7315837
pii: 00003072-202008000-00034
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Nivolumab
31YO63LBSN
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e381-e382Références
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Nucl Med. 2020 Jul;45(7):531-533
pubmed: 32502091
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Eur Respir Rev. 2019 Nov 6;28(154):
pubmed: 31694838
Future Oncol. 2019 Jun;15(16):1911-1920
pubmed: 31020849
Eur Radiol. 2020 Aug;30(8):4398-4406
pubmed: 32211963